Controversial U.S. bill would lift Supreme Court ban on patenting human genes
Share
From Science Magazine:
But the witnesses at the hearing had different interpretations of the bill’s text. The intent to preserveMyriad is “inconsistent with the legislative text that’s been put forward,” said patent policy researcher Charles Duan of the R Street Institute in Washington, D.C., in his testimony. The proposed language could make it possible to patent many kinds of “pure scientific research,” he said. “I don’t think that’s the intent, but … that’s what the language does.”
Featured Publications
Low-Energy Friday: Permissionless Solar
New Jersey Promised a Clean Slate Seven Years Ago. Now, It Can Finally Deliver.
Can prediction markets improve economic news?
Pennsylvania House Approves Open Primary Bill with Bipartisan Support
How Strategic Patenting and Litigation Delay Access to More Affordable Medicines
Safer Solutions: Non-Fatal Opioid Overdoses
Every Car, Everywhere, All at Once









